IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.770
+0.050 (2.91%)
Mar 9, 2026, 4:00 PM EDT - Market closed
IN8bio Market Cap
IN8bio has a market cap or net worth of $17.29 million as of March 9, 2026. Its market cap has decreased by -16.61% in one year.
Market Cap
17.29M
Enterprise Value
9.16M
1-Year Change
-16.61%
Ranking
Category
Stock Price
$1.77
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $17.29M, a decrease of -90.78%. That is a compound annual growth rate of -40.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 16.80M | 70.18% |
| Dec 31, 2025 | 9.87M | -47.05% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genenta Science | 20.15M |
| Intensity Therapeutics | 20.14M |
| Allarity Therapeutics | 19.94M |
| VYNE Therapeutics | 19.83M |
| Cadrenal Therapeutics | 19.36M |
| Citius Pharmaceuticals | 18.69M |
| Pasithea Therapeutics | 18.39M |
| Serina Therapeutics | 16.50M |